IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.
about
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune ResponseMacrophages and Uveitis in Experimental Animal ModelsPhospholipase cε, an effector of ras and rap small GTPases, is required for airway inflammatory response in a mouse model of bronchial asthma.Interleukin 33: a switch-hitting cytokine.IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.MicroRNA-762 is upregulated in human corneal epithelial cells in response to tear fluid and Pseudomonas aeruginosa antigens and negatively regulates the expression of host defense genes encoding RNase7 and ST2.Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.Modulation of epithelial immunity by mucosal fluid.Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in miceControlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunityImplications for Interleukin-33 in solid organ transplantationTREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway.The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovaniChanges in macrophage function modulated by the lipid environment.M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.Macrophage activation and polarization in post-infarction cardiac remodeling.Type 2 innate immune responses and the natural helper cell.Interleukin-33 biology with potential insights into human diseases.The evolutionary role of the IL-33/ST2 system in host immune defence.Th2-type innate immune responses mediated by natural helper cells.Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies.Interleukin-33 in health and disease.IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model.Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.Interleukin 33 mediates type 2 immunity and inflammation in the central nervous system of mice infected with Angiostrongylus cantonensis.Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.Macrophage polarization and allergic asthma.Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.Macrophage Polarization in Leishmaniasis: Broadening Horizons
P2860
Q26743383-4789ED84-70E3-45B2-B4E5-9B72946F4145Q26828497-22640530-E9B4-427C-8FD7-D5E4C7F83B1CQ27345107-2427CBF7-BFE5-4E38-94E6-E9D3E751C8A7Q33987547-062C5E32-8320-46B6-9203-D09B732A79BFQ34289318-ADC1B88B-53C6-420A-8BB7-9991D82F99BFQ34612528-C8A3C023-E424-4C32-8B4E-9B59994B8CC5Q35439783-F4AB498D-2A2F-43ED-8476-B3145BDA9C6BQ35551292-18DE9C58-EEF2-4392-8E99-1117AC266CA9Q36218650-210A3EF9-4725-430D-AE80-32D4F6C6A3FAQ36301170-4A9AB447-F8CB-4281-815E-26F35E630925Q36440299-2ACA3638-1017-4A86-98F5-D5A83FE8E378Q36807908-52AC4D82-3CFC-4839-8125-A4A7FA5EB557Q36856652-BD2634EC-8E8D-445E-BBD6-BC55CEC1EBBEQ37174541-9B34CB81-FB52-448F-9313-800E3CC6E7E1Q37404095-4C8A032D-AAAA-496C-AE6D-971EFC79B27DQ37609295-80E7B5FF-EC37-4C24-A323-F100BE6235EDQ37630894-34F89CF5-92D7-428C-A946-AFEE591F46D6Q37842599-FE061732-4BD0-4D27-A108-7EB958840109Q37868927-643C01DD-0C92-4B6C-B50D-7EFA0B636E5DQ38071241-15524F12-7326-44ED-9300-75DB0F3130F2Q38101646-446CCB64-C5EE-43AC-8CBF-A27E1BDA03C0Q38105069-68FD40B2-083E-4005-B017-07729CE8AF23Q38957840-EA841CEB-5017-4FE6-886E-9FD8046D62D6Q39529075-BC58BF9C-F66A-4055-8E32-291F2E497E72Q39673960-EFD3F72B-7C66-4A28-BA3A-B55727CB86AAQ40246354-D4CD9891-148F-4B2C-A80C-CA2325E2CB67Q41636753-7C906730-BDB0-446F-8070-434C9EF30D65Q44959091-4D51EDFD-66CE-4E1B-A5B7-529162C5FB6AQ46242176-CA9C360C-D520-4BBB-B808-6ECF0EB260F9Q47608848-CA476556-FC0A-45CD-A683-CD37381F758CQ54967737-86761945-A51F-46C3-9EEF-C51380619689Q59138115-42049BEF-EDBA-4BE3-BD72-61EC6AD3CC39
P2860
IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@ast
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@en
type
label
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@ast
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@en
prefLabel
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@ast
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@en
P2093
P2860
P356
P1476
IL-33 shifts macrophage polari ...... udomonas aeruginosa keratitis.
@en
P2093
Elizabeth Szliter
Linda D Hazlett
Ronald P Barrett
Sharon A McClellan
Yunfan Zhang
P2860
P304
P356
10.1167/IOVS.09-3983
P407
P577
2009-11-05T00:00:00Z